An overview of progress in antisense therapeutics

[1] PHARMACOKINETICS, BIODISTRIBUTION, AND STABILITY OF OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES IN MICE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) : 7595 - 7599

[2] ABSORPTION, TISSUE DISTRIBUTION AND IN-VIVO STABILITY IN RATS OF A HYBRID ANTISENSE OLIGONUCLEOTIDE FOLLOWING ORAL-ADMINISTRATION [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 50 (04) : 571 - 576

[3] Bayever E, 1993, Antisense Res Dev, V3, P383

[4] BENNETT CF, 1992, MOL PHARMACOL, V41, P1023

[5] Bennett CF, 1993, J LIPOSOME RES, V3, P85

[6] OLIGODEOXYNUCLEOSIDE PHOSPHOROTHIOATE STABILITY IN SUBCELLULAR EXTRACTS, CULTURE MEDIA, SERA AND CEREBROSPINAL-FLUID [J]. JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 1990, 20 (03): : 259 - 267

[7] CHIANG MY, 1991, J BIOL CHEM, V266, P18162

[8] Chrisey L A, 1993, Antisense Res Dev, V3, P367

[9] COHEN JS, 1993, ANTISENSE RES APPL, P205

[10] CORNISH K.G, 1993, PHARM COMMUN, V3, P239

[1] PHARMACOKINETICS, BIODISTRIBUTION, AND STABILITY OF OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES IN MICE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) : 7595 - 7599

[2] ABSORPTION, TISSUE DISTRIBUTION AND IN-VIVO STABILITY IN RATS OF A HYBRID ANTISENSE OLIGONUCLEOTIDE FOLLOWING ORAL-ADMINISTRATION [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 50 (04) : 571 - 576

[3] Bayever E, 1993, Antisense Res Dev, V3, P383

[4] BENNETT CF, 1992, MOL PHARMACOL, V41, P1023

[5] Bennett CF, 1993, J LIPOSOME RES, V3, P85

[6] OLIGODEOXYNUCLEOSIDE PHOSPHOROTHIOATE STABILITY IN SUBCELLULAR EXTRACTS, CULTURE MEDIA, SERA AND CEREBROSPINAL-FLUID [J]. JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 1990, 20 (03): : 259 - 267

[7] CHIANG MY, 1991, J BIOL CHEM, V266, P18162

[8] Chrisey L A, 1993, Antisense Res Dev, V3, P367

[9] COHEN JS, 1993, ANTISENSE RES APPL, P205

[10] CORNISH K.G, 1993, PHARM COMMUN, V3, P239